Back
Innate Pharma SA Vs. Genfit SA Industry Stock Comparison
Sell
36
IPHYF
Innate Pharma SA
Last Price:
2.20
Seasonality Move:
-9.08%
Buy
52
GNFT
Genfit SA
Last Price:
3.79
Seasonality Move:
-19.68%
Sell
36
Innate Pharma SA (IPHYF)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
- The current Innate Pharma SA [IPHYF] share price is $2.20. The Score for IPHYF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- IPHYF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Genfit SA (GNFT)
is a Buy
Is Genfit SA a Buy, Sell or Hold?
- The current Genfit SA [GNFT] share price is $3.79. The Score for GNFT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- GNFT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IPHYF Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHYF is experiencing slight buying pressure.
IPHYF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 19.31 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.26 - 2.7) | Sell |
| Bollinger Bands (100): | (2.45 - 2.87) | Sell |
GNFT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 59.66 | Buy |
| Chaikin Money Flow: | 3156 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.48 - 3.68) | Buy |
| Bollinger Bands (100): | (3.5 - 3.82) | Buy |
IPHYF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.19 | Buy |
| 20-day SMA: | 2.44 | Sell |
| 50-day SMA: | 2.49 | Sell |
| 200-day SMA: | 2.68 | Sell |
| 8-day EMA: | 2.24 | Sell |
| 20-day EMA: | 2.37 | Sell |
| 50-day EMA: | 2.5 | Sell |
| 200-day EMA: | 2.67 | Sell |
GNFT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.67 | Buy |
| 20-day SMA: | 3.57 | Buy |
| 50-day SMA: | 3.58 | Buy |
| 200-day SMA: | 3.53 | Buy |
| 8-day EMA: | 3.68 | Buy |
| 20-day EMA: | 3.62 | Buy |
| 50-day EMA: | 3.6 | Buy |
| 200-day EMA: | 3.64 | Buy |
Innate Pharma SA Earnings Growth & IPHYF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Genfit SA Earnings Growth & GNFT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $1.07 per share.
Innate Pharma SA Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Genfit SA Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||